Click to read "I love my Caregivers" by Wanda
Low Level Laser Therapy
Low level laser therapy (LLLT) was introduced into the US market in 2006, after the FDA cleared the Riancorp LTU-904 laser therapy units for the treatment of post-mastectomy lymphedema by lymphedema therapists.
The potential of a new treatment modality for lymphedema is an exciting development; however it is important to fully understand how this new treatment works, how well it has been tested, its limitations, and the long term results.
These units are infra-red lasers operating at a wavelength of 904 nanometers. This invisible wavelength penetrates deeply into tissue where it is absorbed by cells and converted into energy that apparently aids in reducing the swelling of post mastectomy lymphedema.
Low level laser therapy is not a cure for lymphedema and laser therapy should be combined with regular lymphedema treatment and home-care.
FDA approval was based primarily on the results of a 64 patient double-blind clinical trial conducted in Australia by Professor Neil Piller.
CAUTIONS ABOUT OTHER LASER PRODUCTS
Other laser, or light products, that have not been clinically tested for lymphedema, are sold through the Internet. A potential purchaser should be aware of possible hazards from these light products:
LASER therapy is approved only for use by a professional lymphedema therapist. Laser therapy is not a “do-it-yourself” project and it is not recommended that a patient purchase the device and try it on their own. If you would like to see a video demonstration as to how the device can be used to treat fibrosis of the ankle, go to the Northwest Lymphedema Center website http://www.nwlymphedemacenter.org/vid_mngmntF.php
© LymphNotes.com 2014. This information does not replace the advice of a qualified health care professional.
Registered user? Log in here: